The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

Procedures include skin grafting, tissue expansion, scar revision, and flap surgery, depending on the extent and location of the burns.

The ANCA / PANCA Test detects antibodies associated with autoimmune diseases, helping in diagnosis and monitoring.

No specific preparation is usually required, but inform your healthcare provider about any medications you are taking.

Results are typically available within a few days, allowing for prompt medical decision-making and disease management.

Elevated levels suggest the presence of an autoimmune disease, such as vasculitis or granulomatosis with polyangiitis.

Yes, the test can help differentiate between types of autoimmune diseases based on the pattern and concentration of antibodies.